Felix Arellano is the Global Head of Pharmacovigilance and Drug Safety at Roche, where they oversee safety activities for the company's extensive portfolio from early development through to marketed products. With over 11 years of leadership experience in pharmacovigilance, Felix previously served as Chief Safety Officer at Pharmacia and held various senior roles in other pharmaceutical companies. Felix's educational background includes a Doctor of Medicine from Universidad Autónoma de Madrid and studies in Pharmacoepidemiology at McGill University. They have been an influential figure in global drug safety, leading teams across multiple countries and managing significant safety operations.
This person is not in any teams
This person is not in any offices